News & Insights
China healthcare news, medical innovations & patient services
China New Biomedical Technology Regulation Takes Effect, Opening Pathways for Cell and Gene Therapy
China Regulation on Clinical Research and Translational Application of Biomedical New Technologies officially took effect on May 1, 2026, establishing a clear legal framework for cell therapy, gene therapy, and regenerative medicine, with priority review for life-threatening conditions.
Source: National Health Commission / Health News
Chinese Surgical Robot Achieves 800 Remote Surgeries Across 12 Countries with 100% Success Rate
Shanghai MicroPort Toumai surgical robot, showcased at the 139th Canton Fair, has completed 800 remote surgeries across 12 countries including a record-breaking 18,000-kilometer operation between China and Brazil, with a perfect success rate.
Sina News / People Daily Health
World-First CDK2/4/6 Inhibitor Approved in China for First-Line Breast Cancer Treatment
China NMPA has approved lerociclib (Saitanxin), the world first CDK2/4/6 inhibitor developed by Chia Tai Tianqing, for first-line treatment of HR-positive, HER2-negative advanced breast cancer, offering a new option to address CDK4/6 inhibitor resistance.
NMPA / Securities Times
CMEF 2026 Concludes in Shanghai, Showcasing Global Medical Technology Breakthroughs
The 93rd China International Medical Equipment Fair (CMEF) wrapped up in Shanghai, drawing 300,000 attendees and featuring thousands of product debuts, including AI-driven healthcare innovations.
CMEF Official / PR Newswire
China to Implement Sweeping Drug Regulatory Reforms on May 15, Introducing Market Exclusivity
Starting May 15, 2026, China will enact its most significant drug regulatory overhaul in two decades, introducing market exclusivity and data protection to accelerate global innovation access.
State Council of the PRC / The Geostrata
Milestone: China's HEC Pharm Secures FDA Approval for Insulin Glargine Injection
HEC Pharm's insulin glargine has become the first Chinese insulin product to receive FDA approval, marking a significant breakthrough for China's biopharmaceutical industry in the global market.
HEC Pharm Official Announcement / East Money
Guangzhou Opens Comprehensive International Medical Tourism Center with 17 Pilot Hospitals
Guangzhou has launched a new international medical tourism center offering end-to-end services from visa processing to post-treatment aftercare, with 17 leading hospitals participating in the pilot program.
Orient News / Guangzhou Health Commission
Chinese Smart Healthcare Innovations Shine at 139th Canton Fair: Surgical Robots, AI Diagnostics, and Capsule Gastroscopy
The 139th Canton Fair showcases China's latest smart healthcare technologies, including a five-in-one orthopedic surgical robot, AI-powered TCM diagnostics, and painless capsule gastroscopy that costs under $90.
Global Times
NMPA Approves Multiple Breakthrough Oncology Drugs in May 2026, Narrowing Global Treatment Access Gap
China's NMPA has approved several novel oncology therapies in May 2026, including ADC drugs and bispecific antibodies that are available in China 6–18 months ahead of European markets, offering new hope for international cancer patients.
ChinaMedAccess
China to Implement Sweeping New Drug Administration Law on May 15, Accelerating Access to Global Innovative Therapies
The most significant overhaul of China's drug regulatory framework in two decades will take effect on May 15, 2026, introducing market and data exclusivity to expedite the arrival of global innovative drugs.
State Council of the PRC
World's First Invasive Brain-Computer Interface Medical Device Approved in China, Included in Medical Insurance within 10 Days
China's NMPA has approved the world's first invasive brain-computer interface (BCI) medical device for hand motor function compensation, which was fast-tracked into Shanghai's medical insurance catalog in a record 10 days.
NMPA / Xinhua News Agency
China Approves World's First Implantable Brain-Computer Interface for Medical Use
China's NMPA has approved the NEO system, the world's first commercially approved implantable brain-computer interface device, for hand motor rehabilitation in patients with tetraplegia.
National Medical Products Administration (NMPA)
NHC Outlines Health Priorities in 15th Five-Year Plan
China's National Health Commission has detailed healthcare development priorities under the 15th Five-Year Plan, emphasizing international medical cooperation and digital health infrastructure.
National Health Commission of China (nhc.gov.cn)
Guangzhou Launches 12-Point Policy Package to Attract International Medical Tourists
Guangzhou has unveiled comprehensive policy measures including a new International Medical Tourism Service Center, support for 17 pilot international hospitals, and streamlined visa assistance for foreign patients seeking treatment in the city.
Guangzhou Health Commission / Yicai Global
Bayer's Stroke Prevention Drug Asundexian Accepted for Review by China's CDE
China's Center for Drug Evaluation has accepted Bayer's marketing authorization application for asundexian, a novel FXIa inhibitor that reduced ischemic stroke by 26% in global Phase III trials.
Bayer AG Official Press Release
China Approves World's First Invasive Brain-Computer Interface for Commercial Clinical Use
China's NMPA has granted Class III medical device certification to the NEO brain-computer interface system, enabling paralyzed patients to regain limited hand function through neural signal-controlled robotic gloves.
NMPA / Sixth Tone
China Approves New CAR-T Therapy for Blood Cancer Treatment
China's NMPA has approved a groundbreaking CAR-T cell therapy, making advanced cancer treatment more accessible to international patients seeking care in Chinese hospitals.
National Medical Products Administration (NMPA)
Huahui Health Receives NMPA Conditional Approval for First-in-Class Hepatitis Antibody
China's NMPA has granted conditional approval to Libevitug, a pioneering first-in-class antibody for viral hepatitis, marking a significant milestone in domestic biopharmaceutical innovation.
NMPA / Huahui Health Official Announcement
Shanghai Hospitals Expand International Insurance Direct Billing
Major Shanghai hospitals including Huashan and Ruijin have expanded their international insurance partnerships, now covering over 100 global insurance providers for direct billing.
Shanghai Municipal Health Commission
West China Hospital Performs First AI-Assisted Robotic Surgery
West China Hospital, Sichuan University has successfully completed its first AI-assisted robotic surgery, marking a milestone in China's medical technology advancement.
West China Hospital Official Announcement
CD-001Gene Therapy Restores Hearing in 90% of Trial Participants Across China
The largest clinical trial of gene therapy for inherited deafness, conducted across eight sites in China, showed that 90% of participants experienced significant hearing restoration.
Mass General Brigham / Harvard Medical School
Beijing United Family Hospital Opens New Oncology Center
Beijing United Family Hospital has inaugurated a state-of-the-art oncology center, offering comprehensive cancer care with international-standard protocols and multidisciplinary teams.
Beijing United Family Hospital
BJ-002CAR-T Cell Therapy: China's Immunotherapy Revolution for Blood Cancer
China has approved multiple CAR-T cell therapy products for hematological malignancies. Leading hospitals in Beijing and Shanghai now offer this groundbreaking treatment at significantly lower costs compared to Western countries.
National Medical Products Administration (NMPA)
Robotic-Assisted Surgery Expands Across China's Top Hospitals
Major Chinese hospitals have adopted Da Vinci and domestically developed robotic surgical systems across urology, gynecology, and general surgery, offering minimally invasive options with faster recovery.
Chinese Journal of Minimally Invasive Surgery
Shenzhen People's Hospital Launches International Medical Department
Shenzhen People's Hospital officially launched its International Medical Department in January 2026, offering one-stop services with multi-language support and overseas insurance direct settlement.
Shenzhen People's Hospital Official Website
SZ-002Shanghai Proton and Heavy Ion Center: Precision Radiation for Complex Cancers
Shanghai's world-class facility offers both proton and carbon-ion therapy, targeting tumors with unprecedented precision while minimizing damage to surrounding healthy tissue.
Shanghai Proton and Heavy Ion Center
CMEF 2026 Showcases AI-Powered Medical Devices and International Cooperation
The 93rd China International Medical Equipment Fair in Shanghai featured breakthrough technologies in AI diagnostics, surgical robotics, and digital health from over 4,000 exhibitors.
CMEF Official / China Medical Device Industry Association
Integrative Medicine: How China Combines TCM with Modern Healthcare
China uniquely offers integrative medicine combining Traditional Chinese Medicine with modern Western approaches, providing evidence-based acupuncture, herbal medicine, and rehabilitation services.
China-Japan Friendship Hospital / WHO Traditional Medicine Centre
TEDA Hospital Achieves Double JCI and HIMSS Stage 7 Certification
TEDA International Cardiovascular Hospital in Tianjin has become the first hospital in China to simultaneously hold both JCI accreditation and HIMSS Stage 7 certification.
TEDA International Cardiovascular Hospital
TJ-002China's Cardiac Innovation: Leading the World in Structural Heart Interventions
Chinese cardiologists are pioneers in TAVR and complex PCI procedures. Fuwai Hospital performs more cardiac surgeries annually than almost any other center globally.
Fuwai Hospital / Chinese Circulation Journal
Neurosurgery and Brain-Computer Interface Research Advances in China
Leading neurosurgery centers in China are advancing deep brain stimulation, minimally invasive brain tumor removal, and early-stage brain-computer interface research for neurological rehabilitation.
Beijing Tiantan Hospital / Chinese Neurosurgical Journal
Reproductive Medicine in China: High-Volume IVF Centers with Advanced Genetic Testing
China's reproductive medicine centers handle some of the highest IVF case volumes globally, with advanced PGT-A/PGT-M genetic testing available at competitive prices.
Chinese Society of Reproductive Medicine
AI-Powered Diagnostics Transform Medical Imaging in Chinese Hospitals
Chinese hospitals are rapidly deploying AI systems for medical imaging analysis, pathology screening, and clinical decision support, enhancing diagnostic accuracy across specialties.
Chinese Journal of Medical Imaging Technology